Biogen (BIIB) PT Lowered to $343 at Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Biogen (BIIB) PT Lowered to $290 at Oppenheimer on CRL for MDD
August 7, 2023 6:28 AM EDTOppenheimer analyst Jay Olson lowered the price target on Biogen (NASDAQ: BIIB) to $290.00 (from $360.00) while maintaining a Outperform rating.
The analyst commented, "The MDD CRL for zuranolone deals BIIB a major blow but not a knockout. We expected BIIB to bolster topline growth... More
